Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults

Leukemia Research

Volumn 30, Issue 9, 2006, Pages 1091-1096

  Bäsecke, Jörg ^a   Podleschny, Martina ^a   Clemens, Robert ^a   Schnittger, Susanne ^b   Viereck, Volker ^a   Trümper, Lorenz ^a   Griesinger, Frank ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cord blood; Healthy newborn; Leukemogenesis; MLL PTD

Indexed keywords

CD19 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD SAMPLING; CARCINOGENESIS; CELL FRACTIONATION; DISEASE ASSOCIATION; EXPOSURE; GENE DUPLICATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HUMAN; LYMPHOID CELL; NEWBORN; NORMAL HUMAN; PARTIAL TANDEM DUPLICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD; B-LYMPHOCYTES; FEMALE; FETAL BLOOD; GENE DUPLICATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, MIXED-CELL; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; T-LYMPHOCYTES;

EID: 33745830494     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.02.005     Document Type: Article

References (28)

1. Ernst P., Fisher J.K., Avery W., Wade S., Foy D., and Korsmeyer S.J. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 6 3 (2004) 437-443
2. Dorshkind K., and Witte O. Got MLL? Definitive hematopoiesis requires MLL gene expression. Mol Cell 13 6 (2004) 765-766
3. Ziemin-van der Poel S., McCabe N.R., Gill H.J., Espinosa III R., Patel Y., Harden A., et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88 23 (1991) 10735-10739
4. Harrison C.J., Cuneo A., Clark R., Johansson B., Lafage-Pochitaloff M., Mugneret F., et al. Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia 12 5 (1998) 811-822
5. Rowley J.D. Rearrangements involving chromosome band 11Q23 in acute leukaemia. Semin Cancer Biol 4 6 (1993) 377-385
6. So C.W., and Cleary M.L. Dimerization: a versatile switch for oncogenesis. Blood 104 2 (2004) 919-922
7. Schnittger S., Wormann B., Hiddemann W., and Griesinger F. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 92 5 (1998) 1728-1734
8. So C.W., Ma Z.G., Price C.M., Dong S., Chen S.J., Gu L.J., et al. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res 57 1 (1997) 117-122
9. Schichman S.A., Caligiuri M.A., Strout M.P., Carter S.L., Gu Y., Canaani E., et al. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 54 16 (1994) 4277-4280
10. Yu M., Honoki K., Andersen J., Paietta E., Nam D.K., and Yunis J.J. MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia 10 5 (1996) 774-780
11. Caligiuri M.A., Strout M.P., Lawrence D., Arthur D.C., Baer M.R., Yu F., et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 58 1 (1998) 55-59
12. Schnittger S., Kinkelin U., Schoch C., Heinecke A., Haase D., Haferlach T., et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 14 5 (2000) 796-804
13. Steudel C., Wermke M., Schaich M., Schakel U., Illmer T., Ehninger G., et al. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer 37 3 (2003) 237-251
14. Shiah H.S., Kuo Y.Y., Tang J.L., Huang S.Y., Yao M., Tsay W., et al. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. Leukemia 16 2 (2002) 196-202
15. Dohner K., Tobis K., Ulrich R., Frohling S., Benner A., Schlenk R.F., et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16-60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 20 15 (2002) 3254-3261
16. Ross M.E., Mahfouz R., Onciu M., Liu H.C., Zhou X., Song G., et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood (2004)
17. Martin M.E., Milne T.A., Bloyer S., Galoian K., Shen W., Gibbs D., et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4 3 (2003) 197-207
18. Whitman S.P., Liu S., Vukosavljevic T., Rush L.J., Yu L., Liu C., et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood 106 1 (2005) 345-352
19. Marcucci G., Strout M.P., Bloomfield C.D., and Caligiuri M.A. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Res 58 4 (1998) 790-793
20. Basecke J., Feuring-Buske M., Brittinger G., Schaefer U.W., Hiddemann W., and Griesinger F. Transcription of AML1 in hematopoietic subfractions of normal adults. Ann Hematol 81 5 (2002) 254-257
21. Bose S., Deininger M., Gora-Tybor J., Goldman J.M., and Melo J.V. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 92 9 (1998) 3362-3367
22. Biernaux C., Sels A., Huez G., and Stryckmans P. Very low level of major BCR-ABL expression in blood of some healthy individuals. Bone Marrow Transplant 17 Suppl. 3 (1996) S45-S47
23. Basecke J., Cepek L., Mannhalter C., Krauter J., Hildenhagen S., Brittinger G., et al. Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia. Blood 100 6 (2002) 2267-2268
24. Weisser M., Kern W., Schoch C., Hiddemann W., Haferlach T., and Schnittger S. RT-PCR based monitoring of MLL-PTD expression levels enables risk assessment in AML patients with normal karyotypes. Haematologica 90 7 (2005) 881-889
25. Basecke J., Griesinger F., Trumper L., and Brittinger G. Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 81 2 (2002) 64-75
26. Hope K.J., Jin L., and Dick J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5 7 (2004) 738-743
27. Terstappen L.W., Huang S., Safford M., Lansdorp P.M., and Loken M.R. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 77 6 (1991) 1218-1227
28. Martin M.E., Milne T.A., Bloyer S., Galoian K., Shen W., Gibbs D., et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4 3 (2003) 197-207